Literature DB >> 1636657

Antibiotic-resistant pneumococcal disease in South African children.

I R Friedland1, K P Klugman.   

Abstract

OBJECTIVE: To determine the incidence of antibiotic-resistant pneumococcal disease and to compare the presentation and outcome of penicillin-resistant infections with penicillin-susceptible infections.
DESIGN: Patient series.
SETTING: General community hospital. PATIENTS: Eighty-three children with penicillin-resistant pneumococcal bacteremia or meningitis and 124 children with penicillin-susceptible pneumococcal bacteremia or meningitis. SELECTION PROCEDURES: Consecutive patients admitted between 1989 and 1991.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: Forty percent of community-acquired isolates and 95% of hospital-acquired isolates were resistant to penicillin. Eighty-three (82%) of 101 penicillin-resistant infections were community acquired. Resistance to chloramphenicol, tetracycline, and erythromycin occurred in 9%, 12%, and 4% of all isolates, respectively. The proportion of penicillin-resistant pneumococci with cefotaxime minimum inhibitory concentrations greater than or equal to 0.5 micrograms/mL increased from 0% in a 1986 study to 21.5% in this study. The sites of infection, underlying diseases, and mortality of patients with penicillin-resistant infections outside the central nervous system did not differ significantly from those of penicillin-susceptible infections.
CONCLUSIONS: The resistance of Streptococcus pneumoniae to beta-lactam antibiotics has increased alarmingly in South Africa. Penicillin-resistant and penicillin-susceptible pneumococcal infections cause a similar spectrum of illness.

Entities:  

Mesh:

Year:  1992        PMID: 1636657     DOI: 10.1001/archpedi.1992.02160200042023

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  29 in total

Review 1.  Diagnosis and treatment of bacterial meningitis.

Authors:  H El Bashir; M Laundy; R Booy
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

2.  Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.

Authors:  G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

Review 3.  The pneumococcal problem.

Authors:  S K Obaro; M A Monteil; D C Henderson
Journal:  BMJ       Date:  1996-06-15

Review 4.  Epidemiology, control and treatment of multiresistant pneumococci.

Authors:  K P Klugman
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 5.  Antibiotic resistant Streptococcus pneumoniae.

Authors:  E J Minton; J T Macfarlane
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

6.  Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008.

Authors:  Penny Crowther-Gibson; Cheryl Cohen; Keith P Klugman; Linda de Gouveia; Anne von Gottberg
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

7.  Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995.

Authors:  M Lovgren; J S Spika; J A Talbot
Journal:  CMAJ       Date:  1998-02-10       Impact factor: 8.262

8.  Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network.

Authors:  A E Simor; M Louie; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

9.  Clinical effects of gemifloxacin on the delay of tuberculosis treatment.

Authors:  Seo Yun Kim; Jae-Joon Yim; Jong Sun Park; Sung Soo Park; Eun Young Heo; Chang-Hoon Lee; Hee Soon Chung; Deog Kyeom Kim
Journal:  J Korean Med Sci       Date:  2013-03-04       Impact factor: 2.153

10.  [Antibiotic sensitivity of important pathogens of bacterial respiratory tract infections in Northeast Germany].

Authors:  O Fierek; P Hinniger; B Panzig
Journal:  Med Klin (Munich)       Date:  1998-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.